Abstract
Experimental and epidemiological studies have shown that the nonsteroidal antiinflammatory drug naproxen may be useful in the treatment of Alzheimer's disease. To investigate the interactions of naproxen with A β dimers, which are the smallest cytotoxic aggregated A β peptide species, we use united atom implicit solvent model and exhaustive replica exchange molecular dynamics. We show that naproxen ligands bind to A β dimer and penetrate its volume interfering with the interpeptide interactions. As a result naproxen induces a destabilizing effect on A β dimer. By comparing the free-energy landscapes of naproxen interactions with A β dimers and fibrils, we conclude that this ligand has stronger antiaggregation potential against A β fibrils rather than against dimers. The analysis of naproxen binding energetics shows that the location of ligand binding sites in A β dimer is dictated by the A β amino acid sequence. Comparison of the in silico findings with experimental observations reveals potential limitations of naproxen as an effective therapeutic agent in the treatment of Alzheimer's disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.